MANUEL
PRAGA TERENTE
Profesor emérito
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoAstraZeneca (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2021
-
Effects of dapagliflozin on mortality in patients with chronic kidney disease: A pre-specified analysis from the DAPA-CKD randomized controlled trial
European Heart Journal, Vol. 42, Núm. 13, pp. 1216-1227